TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | -1 | 6 | 18 | 18 | 24 | 11 |
| S | %wins | 67 | 33 | 33 | 0 | 33 | 33 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/10 19:12 | 9/15/10 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Horak Ivan D | NJ | O | EVP,R,D, | S.dm | -2,763 | 10.67 | 3 | -259 | -68 | 120 | D | 23 | 32 | 3 | -7 | -1 | 1 | -2 | -3 | 3 | 3 | 9 | 11 | -3 | -21 |
2/24/10 16:06 | 2/22/10 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Horak Ivan D | NJ | O | EVP,R,D, | S | -943 | 9.30 | 7 | -101 | -72 | 39 | D | 12 | 57 | 25 | -11 | -14 | -5 | 2 | 0 | -1 | 2 | 11 | 9 | 11 | 17 |
4/7/09 15:44 | 4/3/09 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Horak Ivan D | NJ | O | EVP,R,D, | S.d | -43 | 6.12 | 2 | -7 | -5 | 123 | D | -28 | -36 | -8 | 1 | 2 | -8 | -9 | 0 | -3 | -7 | -3 | 33 | 46 | 76 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |